Tools commonly used in the Artificial Kidney Centers industry for day-to-day tasks and operations.

• Hemodialysis machine
• Peritoneal dialysis machine
• Blood pressure monitor
• Blood glucose monitor
• Dialysate solution
• Catheter insertion kit
• Fistula needle
• Dialysis tubing
• Dialysis filter
• Anticoagulant medication

Common products and services typical of NAICS Code 621492-01, illustrating the main business activities and contributions to the market.

• Hemodialysis treatment centers
• Peritoneal dialysis clinics
• Renal care facilities
• Kidney disease treatment centers
• Nephrology clinics

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Medicare Certification: Artificial Kidney Centers must be certified by Medicare to receive reimbursement for services provided to Medicare beneficiaries. This certification ensures that the center meets certain quality standards and is in compliance with federal regulations. Certification is provided by the Centers for Medicare & Medicaid Services (CMS).
• State Licensing: Artificial Kidney Centers must be licensed by the state in which they operate. Licensing requirements vary by state but typically include minimum staffing levels, equipment standards, and infection control protocols. Licensing is provided by the state health department. Link: varies by state
• Joint Commission Accreditation: Artificial Kidney Centers can seek accreditation from the Joint Commission, an independent organization that evaluates and accredits healthcare organizations. Accreditation demonstrates that the center meets high standards for patient care and safety.
• American Nephrology Nurses Association (ANNA) Certification: ANNA offers certification for nurses who work in nephrology, including those who work in Artificial Kidney Centers. Certification demonstrates a high level of knowledge and expertise in the field.
• National Kidney Foundation (NKF) Accreditation: NKF offers accreditation for Artificial Kidney Centers that meet certain quality standards. Accreditation demonstrates a commitment to providing high-quality care to patients with kidney disease.

A concise historical narrative of NAICS Code 621492-01 covering global milestones and recent developments within the United States.

• The history of Artificial Kidney Centers dates back to the 1940s when Dr. Willem Kolff developed the first dialysis machine. The first successful dialysis treatment was performed in 1945 on a patient suffering from acute renal failure. In the 1960s, the first outpatient dialysis center was established in Seattle, Washington. The 1970s saw the introduction of the first portable dialysis machine, which allowed patients to receive treatment at home. In the 1980s, the use of synthetic membranes in dialysis machines improved the efficiency of the treatment. In recent years, there have been advancements in the development of wearable artificial kidneys, which could provide patients with greater mobility and flexibility in their treatment. In the United States, the first dialysis center was established in 1962 in Seattle, Washington. The 1972 Medicare End-Stage Renal Disease (ESRD) Program provided coverage for dialysis treatment for all eligible patients, which led to a significant increase in the number of dialysis centers across the country. In the 1980s, the introduction of the Prospective Payment System (PPS) for dialysis treatment led to a shift towards outpatient care. In the 1990s, the use of erythropoietin to treat anemia in dialysis patients became widespread. In recent years, there has been a focus on improving the quality of care for dialysis patients, with initiatives such as the Dialysis Facility Compare website, which allows patients to compare the quality of care provided by different dialysis centers.

The anticipated future trajectory of the NAICS 621492-01 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Stable

  The future outlook for the Artificial Kidney Centers industry in the USA is positive. The industry is expected to grow due to the increasing prevalence of kidney diseases and the aging population. According to a report by Grand View Research, the global dialysis market is expected to reach USD 136.15 billion by 2026, growing at a CAGR of 5.9% from 2018 to 2026. The report also states that the increasing prevalence of chronic kidney diseases and the shortage of kidney donors are the major factors driving the growth of the dialysis market. The Artificial Kidney Centers industry is expected to benefit from these trends and continue to grow in the coming years.

Recent groundbreaking advancements and milestones in the Artificial Kidney Centers industry, reflecting notable innovations that have reshaped its landscape.

• Wearable Artificial Kidney: A wearable artificial kidney is a portable device that can be worn like a belt and is designed to perform the functions of a healthy kidney. The device is being developed by the Kidney Project, a collaboration between the University of California, San Francisco and Vanderbilt University. The device is currently in clinical trials and has the potential to improve the quality of life for patients with kidney failure.
• Implantable Artificial Kidney: The implantable artificial kidney is a device that is surgically implanted into the body and is designed to perform the functions of a healthy kidney. The device is being developed by the Kidney Project and is currently in preclinical trials. The device has the potential to eliminate the need for dialysis and improve the quality of life for patients with kidney failure.
• Home Hemodialysis Machines: Home hemodialysis machines are portable devices that allow patients to perform hemodialysis at home. The machines are designed to be easy to use and require minimal training. The machines are being developed by companies such as NxStage Medical and Fresenius Medical Care and have the potential to improve the quality of life for patients with kidney failure.
• Wearable Sensors: Wearable sensors are devices that can be worn on the body and are designed to monitor various health parameters such as blood pressure, heart rate, and oxygen saturation. The sensors are being developed by companies such as BioIntelliSense and have the potential to improve the monitoring of patients with kidney failure.
• Artificial Intelligence: Artificial intelligence is being used to develop predictive models that can help identify patients who are at risk of developing kidney disease. The models are being developed by companies such as RenalytixAI and have the potential to improve the early detection and treatment of kidney disease.